Treatment co-developed by Fudan University scientists proves 'very effective' during testing

Chinese and US scientists have jointly developed a new antibody targeting the Middle East respiratory syndrome virus, which has killed 19 people and put more than 150 in hospitals.

The antibody has proved highly successful on animals, and experts have called for a clinical trial to be held as soon as possible.